XOMA Royalty Corporation

NasdaqGM:XOMA 주식 보고서

시가총액: US$365.4m

XOMA Royalty 미래 성장

Future 기준 확인 5/6

XOMA Royalty은 연간 수입과 매출이 각각 78%와 31.3% 증가할 것으로 예상되고 EPS는 연간 78.6%만큼 증가할 것으로 예상됩니다.

주요 정보

78.0%

수익 성장률

78.6%

EPS 성장률

Biotechs 수익 성장28.3%
매출 성장률31.3%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트08 Nov 2024

최근 미래 성장 업데이트

Recent updates

XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties

Oct 15

News Flash: Analysts Just Made A Notable Upgrade To Their XOMA Royalty Corporation (NASDAQ:XOMA) Forecasts

Aug 14
News Flash: Analysts Just Made A Notable Upgrade To Their XOMA Royalty Corporation (NASDAQ:XOMA) Forecasts

Health Check: How Prudently Does XOMA Royalty (NASDAQ:XOMA) Use Debt?

Aug 02
Health Check: How Prudently Does XOMA Royalty (NASDAQ:XOMA) Use Debt?

XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares

Jun 29

Is XOMA (NASDAQ:XOMA) Using Debt Sensibly?

Apr 03
Is XOMA (NASDAQ:XOMA) Using Debt Sensibly?

Are Investors Undervaluing XOMA Corporation (NASDAQ:XOMA) By 49%?

Sep 01
Are Investors Undervaluing XOMA Corporation (NASDAQ:XOMA) By 49%?

Bearish: Analysts Just Cut Their XOMA Corporation (NASDAQ:XOMA) Revenue and EPS estimates

Aug 11
Bearish: Analysts Just Cut Their XOMA Corporation (NASDAQ:XOMA) Revenue and EPS estimates

XOMA GAAP EPS of -$0.53 misses by $0.37, revenue of $0.98M misses by $3.29M

Aug 04

Forecast: Analysts Think XOMA Corporation's (NASDAQ:XOMA) Business Prospects Have Improved Drastically

May 08
Forecast: Analysts Think XOMA Corporation's (NASDAQ:XOMA) Business Prospects Have Improved Drastically

Xoma Gets The Spotlight

Sep 02

Things Look Grim For XOMA Corporation (NASDAQ:XOMA) After Today's Downgrade

Aug 20
Things Look Grim For XOMA Corporation (NASDAQ:XOMA) After Today's Downgrade

We Think The Compensation For XOMA Corporation's (NASDAQ:XOMA) CEO Looks About Right

May 13
We Think The Compensation For XOMA Corporation's (NASDAQ:XOMA) CEO Looks About Right

Does XOMA (NASDAQ:XOMA) Have A Healthy Balance Sheet?

May 11
Does XOMA (NASDAQ:XOMA) Have A Healthy Balance Sheet?

XOMA EPS misses by $0.55, misses on revenue

May 06

XOMA gets milestone payment from Janssen Biotech

May 03

XOMA's (NASDAQ:XOMA) Earnings Are Of Questionable Quality

Mar 17
XOMA's (NASDAQ:XOMA) Earnings Are Of Questionable Quality

Analysts Are More Bearish On XOMA Corporation (NASDAQ:XOMA) Than They Used To Be

Mar 16
Analysts Are More Bearish On XOMA Corporation (NASDAQ:XOMA) Than They Used To Be

Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions?

Mar 09
Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions?

Did You Miss XOMA's (NASDAQ:XOMA) Impressive 140% Share Price Gain?

Feb 02
Did You Miss XOMA's (NASDAQ:XOMA) Impressive 140% Share Price Gain?

XOMA: A Royalty Aggregator To Watch

Jan 04

XOMA (NASDAQ:XOMA) Has Debt But No Earnings; Should You Worry?

Dec 29
XOMA (NASDAQ:XOMA) Has Debt But No Earnings; Should You Worry?

XOMA prices $22M offering of series A cumulative perpetual preferred stock

Dec 11

Could The XOMA Corporation (NASDAQ:XOMA) Ownership Structure Tell Us Something Useful?

Dec 01
Could The XOMA Corporation (NASDAQ:XOMA) Ownership Structure Tell Us Something Useful?

수익 및 매출 성장 예측

NasdaqGM:XOMA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026493N/AN/A3
12/31/202536-7N/AN/A3
12/31/202428-6N/AN/A3
9/30/202422-35-15-15N/A
6/30/202415-24-8-8N/A
3/31/20246-42-13-18N/A
12/31/20235-46-18-18N/A
9/30/20234-32-18-18N/A
6/30/20234-31-20-20N/A
3/31/20233-30-14-17N/A
12/31/20226-23-13-13N/A
9/30/202240104222N/A
6/30/202241103622N/A
3/31/202241123623N/A
12/31/20213882323N/A
9/30/2021301-1110N/A
6/30/2021296-310N/A
3/31/2021296-211N/A
12/31/20202991010N/A
9/30/20202-13-12-12N/A
6/30/202011-9-18-5N/A
3/31/202011-10-25-6N/A
12/31/201918-2-200N/A
9/30/201920-2-181N/A
6/30/201912-8-27-5N/A
3/31/201913-6-21-6N/A
12/31/20185-13-28-13N/A
9/30/20189-11-30-15N/A
6/30/2018449N/A18N/A
3/31/20185318N/A13N/A
12/31/2017536N/A3N/A
9/30/201748-11N/A15N/A
6/30/201712-39N/A-28N/A
3/31/20172-61N/A-32N/A
12/31/20166-54N/A-34N/A
9/30/201653-11N/A-12N/A
6/30/2016551N/A-19N/A
3/31/201657-7N/A-23N/A
12/31/201555-21N/A-31N/A
9/30/201512-53N/A-77N/A
6/30/201515-67N/A-74N/A
3/31/201518-55N/A-74N/A
12/31/201419-38N/A-78N/A
9/30/201427-83N/A-68N/A
6/30/201428-99N/A-65N/A
3/31/201429-104N/A-60N/A
12/31/201335-124N/A-46N/A

애널리스트 미래 성장 예측

수입 대 저축률: XOMA 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.6% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: XOMA (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: XOMA 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: XOMA 의 수익(연간 31.3% ) US 시장( 8.9% 보다 빠르게 성장할 것으로 예상됩니다. 8.9% 연간).

고성장 수익: XOMA 의 수익(연간 31.3% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: XOMA 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견